Regulatory Control of Radiopharmaceuticals
The health of the nuclear medicine and radiopharmaceutical industry relies on the ability to continue producing answers to the most pressing medical problems and to produce a continuous supply of the needed materials. Thus there is the need not only for research at the leading edge of medicine but for steady production for a number of years after the initial introduction of a product, especially, so the use of the material may be disseminated from the academic centers to the community hospitals.
KeywordsRadioactive Material Package Insert Agreement State Executive Branch Nuclear Regulatory Commission
Unable to display preview. Download preview PDF.